Regulatory Burdens And Political Opposition Will Curb Nuclear Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
01 Jun 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$120.00
44.6% overvalued intrinsic discount16 Aug
US$173.50
1Y
74.5%7D
-2.5%